Molecular characterization of Clostridium botulinum isolates from foodborne outbreaks in Thailand, 2010

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Wangroongsarb, Piyada ^a   Kohda, Tomoko ^b   Jittaprasartsin, Chutima ^a   Suthivarakom, Karun ^a   Kamthalang, Thanitchi ^a   Umeda, Kaoru ^c   Sawanpanyalert, Pathom ^d   Kozaki, Shunji ^b   Ikuta, Kazuyoshi ^e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Osaka Prefecture University   (Japan)

^c OSAKA CITY INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^d Department of Medical Sciences ^*  (Thailand)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BOTR GENE; BOTULISM; CLINICAL ARTICLE; CLOSTRIDIUM BOTULINUM; EPIDEMIC; FOOD POISONING; HA17 GENE; HA33 GENE; HA70 GENE; HUMAN; LABORATORY TEST; MOUSE; NONHUMAN; NTNH GENE; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEQUENCE ANALYSIS; THAILAND;

ANIMALS; BASE SEQUENCE; BIOLOGICAL ASSAY; BOTULISM; CLOSTRIDIUM BOTULINUM; CLUSTER ANALYSIS; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTORY, 21ST CENTURY; HUMANS; MICE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MULTIPLEX POLYMERASE CHAIN REACTION; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; THAILAND;

EID: 84899904819     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077792     Document Type: Article

References (62)

1. Swaddiwudhipong W, Wongwatcharapaiboon P (2000) Foodborne botulism outbreaks following consumption of home-canned bamboo shoots in Northern Thailand. J Med Assoc Thai 83: 1021-1025.
2. Centers for Disease Control and Prevention (1999) Foodborne botulism associated with home-canned bamboo shoots, Thailand, 1998. MMWR 48: 437-439.
3. Kongsaengdao S, Samintarapanya K, Rusmeechan S, Wongsa A, Pothirat C, et al. (2006) An Outbreak of botulism in Thailand: Clinical manifestations and management of severe respiratory failure. Clin Infect Dis 43: 1247-1256. (Pubitemid 44706449)
4. Centers for Disease Control and Prevention (2006) Botulism from Home-Canned Bamboo Shoots - Nan Province, Thailand, March 2006. MMWR 55: 389-392.
5. Hatheway CL (1995) Botulism: the present status of the disease. Curr Top Microbiol Immunol 195: 55-75.
6. Hatheway CL (1988) Botulism. In: Balows A, Hausler WH, Ohashi M, Turnano A, editors. Laboratory diagnosis of infectious diseases principles and practice. New York: Springer. pp. 111-133.
7. Szilagyi M, Rivera VR, Neal D, Merrill GA, Poli MA (2000) Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B. Toxicon 38: 381-389. (Pubitemid 29531579)
8. Sharma SK, Ferreira JL, Eblen BS, Whiting RC (2006) Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies. Appl Environ Microbiol 72: 1231-1238. (Pubitemid 43271231)
9. Maslanka S, Luquez C, Raphael B, Dykes J, Joseph L (2011) Utility of Botulinum Toxin ELISA A, B, E, F kits for clinical laboratory investigations of human botulism. TBJ 2: 72-92.
10. Bagramyan K, Barash JR, Arnon SS, Kalkum M (2008) Attomolar detection of botulinum toxin type A in complex biological matrices. PloS ONE 3: e2041.
11. Dowell VR Jr, Hawkins TM (1987) Laboratory methods in anaerobic bacteriology CDC Laboratory Manual. Atlanta: DHEW Publication. 8272 p.
12. ed. Blacksburg: Virginia Polytechnic Institute and State University. 156 p.
13. Hatheway CL, Dang C (1994) Immunogenicity of neurotoxins of Clostridium botulinum. In: Jankovic J, Hallett M, editors. Therapy with botulinum toxin. New York: Marcel Dekker. pp. 93-107.
14. Brett MM (1998) Evaluation of the use of the bioMerieux Rapid ID32A for the identification of Clostridium botulinum. Lett Appl Microbiol 26: 81-84.
15. Lindström MK, Jankola HM, Hielm S, Hyytiä EK, Korkeala HJ (1999) Identification of Clostridium botulinum with API 20 A, Rapid ID 32 A and RapID ANA II. FEMS Immunol Med Microbiol 24: 267-274. (Pubitemid 29332602)
16. Lindström MK, Keto R, Markkula A, Nevas M, Hielm S, et al. (2001) Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material. Appl Environ Microbiol 67: 5694-5699. (Pubitemid 33641006)
17. De Medici D, Anniballi F, Wyatt GM, Lindström M, Messelhäusser U, et al. (2009) Multiplex PCR for detection of botulinum neurotoxin-producing clostridia in clinical, food, and environmental samples. Appl Environ Microbiol 75: 6457-6461.
18. Aranda E, Rodriguez MM, Asensio MA, Cordoba JJ (1997) Detection of Clostridium botulinum types A, B, E and F in foods by PCR and DNA probe. Lett Appl Microbiol 25: 186-190. (Pubitemid 27395999)
19. Popoff MR (1995) Ecology of neurotoxigenic strains of clostridia. Curr Top Microbiol Immunol 195: 1-29.
20. Sonnabend O, Sonnabend W, Heinzle R, Sigrist T, Dirnhofer R, et al. (1981) Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J Infect Dis 143: 22-27. (Pubitemid 11152593)
21. Sonnabend WF, Sonnabend UP, Krech T (1987) Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme. Appl Environ Microbiol 53: 1880-1884.
22. Macdonald TE, Helma CH, Shou Y, Valdez YE, Ticknor LO, et al. (2011) Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing. Appl Environ Microbiol 77: 8625-8634.
23. Jacobson MJ, Lin G, Tepp W, Dupuy J, Stenmark P, et al. (2011) Purification, modeling, and analysis of botulinum neurotoxin subtype A5 (BoNT/A5) from Clostridium botulinum strain A661222. Appl Environ Microbiol 77: 4217-4222.
24. Kalb SR, Baudys J, Rees JC, Smith TJ, Smith LA, et al. (2012) De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics. Anal Bioanal Chem 403: 215-226.
25. Umeda K, Seto Y, Kohda T, Mukamoto M, Kozaki S (2009) Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan. J Clin Microbiol 47: 2720-2728.
26. Raphael BH, Lautenschlager M, Kalb SR, de Jong LI, Frace M, et al. (2012) Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtype. BMC Microbiol 12: 245.
27. Raphael BH, Choudoir MJ, Lúquez C, Fernández R, Maslanka SE (2010) Sequence diversity of genes encoding botulinum neurotoxin type F. Appl Environ Microbiol 76: 4805-4812.
28. Raffestin S, Couesnon A, Pereira Y, Mazuet C, Popoff MR (2009) Botulinum and tetanus neurotoxins: molecular biology, toxin gene regulation and mode of action. In: Bruggemann H, Gottschalk G, editors. Clostridia: molecular biology in the post-genomic era. Norfolk: Caister Academic Press. pp. 1-28.
29. Moriishi K, Koura M, Abe N, Fujii N, Fujinaga Y, et al. (1996) Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochem Biophys Acta 1307: 123-126.
30. Nakamura K, Kohda T, Shibata Y, Tsukamoto K, Arimitsu H, et al. (2012) Unique biological activity of botulinum D/C mosaic neurotoxin in murine species. Infect Immun 80: 2886-2893.
31. Woudstra C, Skarin H, Anniballi F, Fenicia L, Bano L, et al. (2012) Neurotoxin gene profiling of Clostridium botulinum types C and D native to different countries within Europe. Appl Environ Microbiol 78: 3120-3127.
32. Roe DE, Finegold SM, Citron DM, Goldstein EJC, Wexler HM, et al. (2002) Multilaboratory comparison of growth characteristics for anaerobes, using 5 different agar media. Clin Infect Dis 35: S36-39.
33. Umeda K, Seto Y, Kohda T, Mukamoto M, Kozaki S (2010) A novel multiplex PCR method for Clostridium botulinum neurotoxin type A gene cluster typing. Microbiol Immunol 54: 308-312.
34. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. BMC 23: 2947-2948. (Pubitemid 350162903)
35. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol 28: 2731-2739.
36. Takeshi K, Fujinaga Y, Inoue K, Nakajima H, Oguma K, et al. (1996) Simple method for detection of Clostridium botulinum type A to F neurotoxin genes by polymerase chain reaction. Microbiol Immunol 40: 5-11.
37. Franciosa G, Floridi F, Maugliani A, Aureli P (2004) Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains. Appl Environ Microbiol 70: 7192-7199. (Pubitemid 39643783)
38. Cordoba JJ, Collins MD, East AK (1995) Studies on the Genes Encoding Botulinum Neurotoxin Type A of Clostridium botulinum from a Variety of Sources. Syst Appl Microbiol 18: 13-22.
39. Hill KK, Xie G, Foley BT, Smith TJ, Munk AC, et al. (2009) Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains. BMC Biol 7: 66.
40. Hutson RA, Zhou Y, Collins MD, Johnson EA, Hatheway CL, et al. (1996) Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J Biol Chem 271: 10786-10792. (Pubitemid 26145816)
41. Hill KK, Smith TJ, Helma CH, Ticknor LO, Foley BT, et al. (2007) Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol 189: 818-832. (Pubitemid 46183856)
42. Binz T, Kurazono H, Wille M, Frevert J, Wernars K, et al. (1990) The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J Biol Chem 265: 9153-9158.
43. Oguma K, Fujinaga Y, Inoue K (1995) Structure and function of Clostridium botulinum toxins. Microl Immunol 39: 161-168.
44. Whelan SM, Elmore MJ, Bodsworth NJ, Brehm JK, Atkinson T, et al. (1992) Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence. Appl Environ Microbiol 58: 2345-2354.
45. Zhou Y, Sugiyama H, Nakano H, Johnson EA (1995) The genes for the Clostridium botulinum type G toxin complex are on a plasmid. Infect Immun 63: 2087-2091.
46. Franciosa G, Maugliani A, Scalfaro C, Aureli P (2009) Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains. PloS ONE 4: e4829.
47. Eklund MW, Poysky FT, Mseitif LM, Strom MS (1988) Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G. Appl Environ Microbiol 54: 1405-1408.
48. Inoue K, Iida H (1970) Conversion of toxigenicity in Clostridium botulinum type C. Jpn J Microbiol 14: 87-89.
49. Eklund MW, Poysky FT, Reed SM (1972) Bacteriophage and the toxigenicity of Clostridium botulinum type D. Nat New Biol 235: 16-17.
50. Carter AT, Paul CJ, Mason DR, Twine SM, Alston MJ, et al. (2009) Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics 10: 115.
51. Johnson EA (1999) Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins. Annu Rev Microbiol 53: 551-575.
52. Tsukamoto K, Kohda T, Mukamoto M, Takeuchi K, Ihara H, et al. (2005) Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J Biol Chem 280: 35164-35171. (Pubitemid 41532703)
53. Simpson LL (2004) Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 44: 167-193.
54. Mukherjee J, McCann C, Ofori K, Hill J, Baldwin K, et al. (2012) Sheep monoclonal antibodies prevent systemic effects of botulinum neurotoxin A1. Toxins 4: 1565-1581.
55. Chow SK, Casadevall A (2012) Monoclonal antibodies and toxins - a perspective on function and isotype. Toxins 4: 430-454.
56. Mowry MC, Meagher M, Smith L, Marks J, Subramanian A (2004) Production and purification of a chimeric monoclonal antibody against botulinum neurotoxin serotype A. Protein Expr Purif 37: 399-408. (Pubitemid 39187978)
57. Lou J, Geren I, Garcia-Rodriguez C, Forsyth CM, Wen W, et al. (2010) Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating. Protein Eng Des Sel 23: 311-319.
58. Matsumura T, Jin Y, Kabumoto Y, Takegahara Y, Oguma K, et al. (2008) The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell Microbiol 10: 355-364.
59. Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, et al. (2005) Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun 73: 5450-5457. (Pubitemid 41192979)
60. Smith TJ, Hill KK, Foley BT, Detter JC, Munk AC, et al. (2007) Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3,/Ba4 and/B1 clusters are located within plasmids. PloS ONE 2: e1271.
61. Kelly BG, Vespermann A, Bolton DJ (2009) The role of horizontal gene transfer in the evolution of selected foodborne bacterial pathogens. Food Chem Toxicol 47: 951-968.
62. Arndt JW, Jacobson MJ, Abola EE, Forsyth CM, Tepp WH, et al. (2006) A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. J Mol Biol 362: 733-742. (Pubitemid 44404084)